The state-of-the-art machine will be available at the Aster International Institute of Oncology, Aster Whitefield
- The new machine will set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
Bangalore, 10th October 2024: 
In a pioneering move that sets a new benchmark in cancer treatment, Aster DM Healthcare, one of the largest integrated healthcare company in India, has become the first healthcare facility in the country—to implement Intra-Operative Electron Radiation Therapy (IOeRT), marking a seminal shift in cancer care. The new state-of-the-art medical facility is available at the Aster International Institute of Oncology (AIIO), Aster Whitefield Hospital, Bengaluru and represents a significant leap forward in the hospital’s commitment to providing the highest quality treatment options for cancer patients. Aster International Institute of Oncology (AIIO) at Aster Whitefield Hospital is a center of excellence for comprehensive cancer care, specializing in cutting-edge treatments and robotic surgery, along with SGRT which is the first in Karnataka. Backed by leading specialists and advanced technology, AIIO’s introduction of IOeRT, will further enhance its world-class oncology services.
IOeRT – an innovative form of radiotherapy, delivers concentrated radiation directly to the tumor site during surgery, reducing the need for multiple post-operative radiation sessions and protecting surrounding healthy tissues from unnecessary exposure. By targeting any remaining microscopic cancer cells immediately after tumor removal, this therapy not only increases the chances of successful treatment but also improves patient outcomes and recovery times. Aster’s integration of IOeRT underscores its dedication to advancing comprehensive cancer care. Backed by a team of skilled surgeons, radiation oncologists, and support staff, the hospital provides a personalized, patient-centered approach that integrates the latest medical advancements with compassionate care.
Alisha Moopen, Deputy Managing Director, Aster DM Healthcare, highlighting the significance of this technological leap, said: “It is with great pleasure that we announce the launch of the Intraoperative Electron Radiation Therapy (IOeRT) machine today, the first of its kind technology in India which introduces a new dimension in cancer treatment for the Indian healthcare sector. With the integration of this advanced technology, our hospital is stepping into a new frontier of precision oncology, offering treatments that are more targeted, effective, and less invasive thus enabling faster recovery for patients. We aim to set new benchmarks for treatment protocols, ensuring that patients have access to the most sophisticated tools and techniques available globally. By integrating cutting-edge innovations, we strive to not only enhance the quality of treatment for our patients but also reduce recovery time enabling a quicker return to normal life for our patients. We believe that the future of healthcare lies in combining precision, efficiency, and patient comfort, and we are dedicated to leading that transformation.”
Dr. Somashekhar S P, Global Director- Aster International Institute of Oncology, Chairman – Medical Advisor Board, Aster DM Healthcare: “The Aster International Institute of Oncology is a state of the art multidisciplinary international standard cancer care institute backed offering cutting edge technologies and latest innovations in cancer care. With IOeRT, we can offer new hope to patients facing complex and advanced cancers, where conventional treatments often fall short. The precision of this technology allows us to target residual cancer cells with unparalleled accuracy, leading to fewer side effects and a better chance of recovery. This breakthrough is set to significantly impact cancer care, reducing recurrence rates and improving long-term outcomes.”
As India braces for a projected 57.5% increase in cancer cases by 2040, according to the GLOBOCAN report, IOeRT offers a critical solution to address the growing burden of cancer. It is particularly effective in treating complex cancers such as breast, gastrointestinal, and lung cancer, where precision and early intervention are key to successful treatment.
The introduction of IOeRT at Aster Whitefield Hospital underscores the hospital’s commitment to adopting cutting-edge technologies and setting new standards for cancer care in India. As the country continues to battle the increasing incidence of cancer, Aster is leading the charge by offering patients more precise, effective, and efficient treatment options.
Dr. M S Beliappa, HOD and Lead Consultant – Radiation Oncology, Aster Hospitals, Bangalore, remarked: “We are bringing the next-generation IOeRT advancement in cancer treatment, offering unparalleled precision in delivering high-dose radiation. This technology not only enhances treatment outcomes but also allows patients to experience faster recovery with fewer side effects, revolutionizing how we approach cancer care in India.”
Building on this local achievement, Dr Felipe Calvo, Co- Director of the Department of Radiation Oncology at Cancer Centre Clinica Universidad de Navarra (Madrid): “The adoption of IOeRT in India represents a major leap in cancer care. This technology, which has proven highly effective in Europe, is now set to transform outcomes for Indian patients. By delivering targeted radiation during surgery, IOeRT reduces the risk of recurrence and significantly improves the quality of life for those facing difficult-to-treat cancers.”
Francesco Zanetti, President & CEO of SIT, expressed his excitement: “Our partnership with Aster Whitefield Hospital in bringing IOeRT to India is a pivotal moment in the advancement of cancer care. At SIT, we are dedicated to developing state-of-the-art cancer treatment technologies, and IOeRT stands out as one of the most promising innovations in recent years. This precision-focused equipment will empower oncologists in India to offer more effective, personalized treatments, ultimately improving survival rates and quality of care.”
